Search

Your search keyword '"Pellicelli A"' showing total 1,207 results
Start Over Author "Pellicelli A"
1,207 results on '"Pellicelli A"'

3. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

Author

Loreta A. Kondili, Giuseppina Brancaccio, Maria Elena Tosti, Barbara Coco, Maria Giovanna Quaranta, Vincenzo Messina, Alessia Ciancio, Filomena Morisco, Valentina Cossiga, Ernesto Claar, Valerio Rosato, Marianna Ciarallo, Irene Cacciola, Francesca Romana Ponziani, Lucia Cerrito, Roberta Coppola, Francesco Longobardi, Elisa Biliotti, Alessia Rianda, Francesco Barbaro, Nicola Coppola, Maria Stanzione, Francesco Barchiesi, Stefano Fagiuoli, Mauro Viganò, Marco Massari, Francesco Paolo Russo, Alberto Ferrarese, Diletta Laccabue, Vito Di Marco, Pierluigi Blanc, Aldo Marrone, Giulia Morsica, Alessandro Federico, Donatella Ieluzzi, Alba Rocco, Francesco Giuseppe Foschi, Alessandro Soria, Ivana Maida, Luchino Chessa, Michele Milella, Elena Rosselli Del Turco, Salvatore Madonia, Liliana Chemello, Ivan Gentile, Pierluigi Toniutto, Matteo Bassetti, Lorenzo Surace, Leonardo Baiocchi, Adriano Pellicelli, Adriano De Santis, Massimo Puoti, Elisabetta Degasperi, Grazia Anna Niro, Anna Linda Zignego, Antonio Craxi, Giovanni Raimondo, Teresa Antonia Santantonio, Maurizia Rossana Brunetto, Giovanni Battista Gaeta, Alessio Aghemo, Chiara Baiguera, Pier Maria Battezzati, Sara Battistella, Maria Grazia Bavetta, Costanza Bertoni, Carolina Boni, Paola Brambilla, Antonella Bray, Federica Briano, Enrico Carmenini, Francesco Castelli, Luisa Cavalletto, Federica Cerini, Luciana Chidichimo, Elisa Colella, Giuliana Cologni, Silvia Como, Romina Corsini, Chiara Costa, Rosa Cotugno, Silvia Cretella, Fernando De Angelis, Pasqualina De Leo, Giovanni Di Perri, Elisabetta Falbo, Luigina Ferrigno, Ezio Fornasiere, Daniela Francisci, Pietro Gatti, Pietro Lampertico, Ilaria Lenci, Anna Licata, Alfredo Marzano, Antonio Mastroianni, Cesare Mazzaro, Monica Monti, Gerardo Nardone, Laura Ambra Nicolini, Nicola Passigato, Maria Bruna Pasticci, Piera Pierotti, Biagio Pinchera, Teresa Pollicino, Carmen Porcu, Giulia Quartini, Gabriele Rancatore, Mario Romeo, Maria Grazia Rumi, Annalisa Saracino, Ornella Schioppa, Ilaria Serio, Roberta Soffredini, Xhimi Tata, Marco Tizzani, Matteo Tonnini, Carlo Torti, Daniela Valenti, Serena Zaltron, and Alessia Zoncada

Subjects
Cohort, IFN treatment, Comorbidities, Infectious and parasitic diseases, RC109-216
Abstract

Background and Aims: We aimed to characterize the epidemiologic and comorbidities profiles of patients with chronic Hepatitis D (CHD) followed in clinical practice in Italy and explored their interferon (IFN) eligibility. Methods: This was a cross-sectional study of the PITER cohort consisting of consecutive HBsAg-positive patients from 59 centers over the period 2019-2023. Multivariable analysis was performed by logistic regression model. Results: Of 5492 HBsAg-positive enrolled patients, 4152 (75.6%) were screened for HDV, 422 (10.2%) were anti-HDV positive. Compared with HBsAg mono-infected, anti-HDV positive patients were more often younger, non-Italians, with a history of drug use, had elevated alanine transaminase (ALT), cirrhosis, or hepatocellular carcinoma (HCC). Compared with Italians, anti-HDV positive non-Italians were younger (42.2% age ≤ 40 years vs. 2.1%; P < 0.001), more often females (males 43.0% vs. 68.6%; P < 0.001) with less frequent cirrhosis and HCC. HDV-RNA was detected in 63.2% of anti-HDV-positive patients, who were more likely to have elevated ALT, cirrhosis, and HCC. Extrahepatic comorbidities were present in 47.4% of anti-HDV positive patients and could affect the eligibility of IFN-containing therapies in at least 53.0% of patients in care. Conclusions: CHD affects young, foreign-born patients and older Italians, of whom two-thirds had cirrhosis or HCC. Comorbidities were frequent in both Italians and non-Italians and impacted eligibility for IFN.

Published
2024
Full Text
View/download PDF

6. From Spontaneous to Strategic: Integrating Street Experiments into Urban Planning Practices

Author

Pellicelli, Gloria, Marinelli, Lea Jeanne, Zazzi, Michele, Rossetti, Silvia, Goos, Gerhard, Series Editor, Hartmanis, Juris, Founding Editor, Bertino, Elisa, Editorial Board Member, Gao, Wen, Editorial Board Member, Steffen, Bernhard, Editorial Board Member, Yung, Moti, Editorial Board Member, Gervasi, Osvaldo, editor, Murgante, Beniamino, editor, Garau, Chiara, editor, Taniar, David, editor, C. Rocha, Ana Maria A., editor, and Faginas Lago, Maria Noelia, editor

Published
2024
Full Text
View/download PDF

7. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

Author

Aghemo, Alessio, Baiguera, Chiara, Battezzati, Pier Maria, Battistella, Sara, Bavetta, Maria Grazia, Bertoni, Costanza, Boni, Carolina, Brambilla, Paola, Bray, Antonella, Briano, Federica, Carmenini, Enrico, Castelli, Francesco, Cavalletto, Luisa, Cerini, Federica, Chidichimo, Luciana, Colella, Elisa, Cologni, Giuliana, Como, Silvia, Corsini, Romina, Costa, Chiara, Cotugno, Rosa, Cretella, Silvia, De Angelis, Fernando, De Leo, Pasqualina, Perri, Giovanni Di, Falbo, Elisabetta, Ferrigno, Luigina, Fornasiere, Ezio, Francisci, Daniela, Gatti, Pietro, Lampertico, Pietro, Lenci, Ilaria, Licata, Anna, Maida, Ivana, Marzano, Alfredo, Mastroianni, Antonio, Mazzaro, Cesare, Monti, Monica, Nardone, Gerardo, Nicolini, Laura Ambra, Passigato, Nicola, Pasticci, Maria Bruna, Pierotti, Piera, Pinchera, Biagio, Pollicino, Teresa, Porcu, Carmen, Quartini, Giulia, Rancatore, Gabriele, Romeo, Mario, Rumi, Maria Grazia, Saracino, Annalisa, Schioppa, Ornella, Serio, Ilaria, Soffredini, Roberta, Tata, Xhimi, Tizzani, Marco, Tonnini, Matteo, Torti, Carlo, Valenti, Daniela, Zaltron, Serena, Zoncada, Alessia, Kondili, Loreta A., Brancaccio, Giuseppina, Tosti, Maria Elena, Coco, Barbara, Quaranta, Maria Giovanna, Messina, Vincenzo, Ciancio, Alessia, Morisco, Filomena, Cossiga, Valentina, Claar, Ernesto, Rosato, Valerio, Ciarallo, Marianna, Cacciola, Irene, Ponziani, Francesca Romana, Cerrito, Lucia, Coppola, Roberta, Longobardi, Francesco, Biliotti, Elisa, Rianda, Alessia, Barbaro, Francesco, Coppola, Nicola, Stanzione, Maria, Barchiesi, Francesco, Fagiuoli, Stefano, Viganò, Mauro, Massari, Marco, Russo, Francesco Paolo, Ferrarese, Alberto, Laccabue, Diletta, Di Marco, Vito, Blanc, Pierluigi, Marrone, Aldo, Morsica, Giulia, Federico, Alessandro, Ieluzzi, Donatella, Rocco, Alba, Foschi, Francesco Giuseppe, Soria, Alessandro, Chessa, Luchino, Milella, Michele, Rosselli Del Turco, Elena, Madonia, Salvatore, Chemello, Liliana, Gentile, Ivan, Toniutto, Pierluigi, Bassetti, Matteo, Surace, Lorenzo, Baiocchi, Leonardo, Pellicelli, Adriano, De Santis, Adriano, Puoti, Massimo, Degasperi, Elisabetta, Niro, Grazia Anna, Zignego, Anna Linda, Craxi, Antonio, Raimondo, Giovanni, Santantonio, Teresa Antonia, Brunetto, Maurizia Rossana, and Gaeta, Giovanni Battista

Published
2024
Full Text
View/download PDF

8. Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication

Author

Romina Salpini, Lorenzo Piermatteo, Giulia Torre, Stefano D'Anna, Sohaib Khan, Leonardo Duca, Ada Bertoli, Simone La Frazia, Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, Pierpaolo Paba, Marco Ciotti, Ilaria Lenci, Simona Francioso, Caterina Paquazzi, Miriam Lichtner, Claudio Mastroianni, Francesco Santopaolo, Giuseppe De Sanctis, Adriano Pellicelli, Giovanni Galati, Alessandra Moretti, Katia Casinelli, Luciano Caterini, Nerio Iapadre, Giustino Parruti, Iacopo Vecchiet, Maurizio Paoloni, Massimo Marignani, Francesca Ceccherini-Silberstein, Leonardo Baiocchi, Sandro Grelli, Loredana Sarmati, and Valentina Svicher

Subjects
Hepatitis D virus, Hepatitis B virus, HDV prevalence, HDV-RNA quantification, HDV chronic infection, Infectious and parasitic diseases, RC109-216
Abstract

Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its fluctuations over time and we provide an extensive characterization of HDV-infected patients. Methods: The rate of HDV seroprevalence and HDV chronicity was assessed in 1579 hepatitis B surface antigen (HBsAg)+ patients collected from 2005 to 2022 in Central Italy. Results: In total, 45.3% of HBsAg+ patients received HDV screening with an increasing temporal trend: 15.6% (2005-2010), 45.0% (2011-2014), 49.4% (2015-2018), 71.8% (2019-2022). By multivariable model, factors correlated with the lack of HDV screening were alanine-aminotransferase (ALT) less than two times of upper limit of normality (

Published
2024
Full Text
View/download PDF

9. The impact of road accidents on hospital admissions and the potential of ADAS in containing health expenditure: Evidence from Piedmont data

Author

Elsa Basili, Carla Caschili, Bruno Dalla Chiara, and Michela Pellicelli

Subjects
Cost of hospitalisation, Road accidents, Public health, ADAS (Advanced Driver Assistance Systems), Road safety, Social costs of accidents, Transportation and communications, HE1-9990
Abstract

On average, more than 3,600 people die every day on world’s roads: road accidents result in over 1.3 million deaths and 50 million injuries annually, placing a significant burden on society and generating substantial economic costs for Governments and Regions, which are responsible for healthcare expenditures.This study proposes and applies a novel methodology aimed at quantifying the effects obtainable from the use of the Advanced Driver Assistance Systems (ADAS) on the base of a real case, in economic terms as well.The real case consists on the analysis of a very large dataset regarding public health and hospital admissions, made possible by the exceptional access to the internal database, available for this scope, of the Piedmont Region (IT).Unlike the decades that have passed, it is now conceivable to identify transport related technological solutions that make it possible to prevent, sometimes even avoid, road accidents or at least reduce their severity. These solutions can be identified in ADAS. In a nutshell, their aim is to create a protective layer that mitigates the risk of accidents or reduces their severity. This concept is analogous to the “onion diagram” used in the railway sector, where multiple layers of protection prevent a single failure from leading to an accident.In essence, ADAS aim to introduce the industrial concept of fail-safe into road transport, at least providing it with a pre-alert: safety has been so far delegated only to the driver’s alertness, caution and dexterity.Through the selective analysis of the health costs linked to road accidents, it is possible to quantify the elements considered important for the choices of public decision-makers on both subjects of health and sustainable mobility: in the Piedmont region, the average cost of a hospitalization following a road accident in 2013 was significantly higher than a hospitalization due to general trauma and values have remained similar in the following years. In the same period, road accidents accounted for 15% of the total number of injuries due to trauma, which implies this share can be affected by the adoption of ADAS, so as analysed within this paper for the years 2017–2019, i.e. before the COVID-19 pandemic.The weight of road accidents on hospitalisation is quantified: on the base of a huge Italian database, the average costs of hospitalisation due to loss of control is quantified. The role of ADAS (Advanced Driver Assistance Systems) for reducing costs of hospitalisation emerges.

Published
2024
Full Text
View/download PDF

15. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis

Author

Scaravaglio, Miki, Nofit, Eugenia, Gallo, Paolo, Galati, Giovanni, Pezzato, Francesco, Rollo, Paolo, D’Ovidio, Erica, Coco, Barbara, Tortora, Annalisa, Fiorini, Cecilia, Venere, Rosanna, Scifo, Gaetano, Cannavò, Mariarita, Feletti, Valentina, Pizzolante, Fabrizio, Giannini, Edoardo Giovanni, Cotugno, Rosa, Fanella, Silvia, Losito, Francesco, Grassi, Giuseppe, Manfredi, Giulia Francesca, Buzzanca, Valerio, Omazzi, Barbara, Casella, Silvia, Zani, Francesca, Ricci, Chiara, Bellia, Valentina, Abenavoli, Ludovico, Morelli, Olivia, Crocè, Lory Saveria, Scivetti, Paolo, Panero, Antonio, Boano, Valentina, Poggi, Guido, Gimignani, Giancarlo, Conforti, Alessandro, Frazzetto, Evelise, Rapisarda, Laura, Demma, Shrin, De Vincentis, Antonio, Ampuero, Javier, Terracciani, Francesca, D’Amato, Daphne, Gerussi, Alessio, Cristoferi, Laura, Cazzagon, Nora, Bonaiuto, Emanuela, Floreani, Annarosa, Calvaruso, Vincenza, Cadamuro, Luca, Degasperi, Elisabetta, Morgando, Anna, Vanni, Ester, Lleo, Ana, Colapietro, Francesca, Alvaro, Domenico, Castellaneta, Antonino, Labanca, Sara, Viganò, Mauro, Distefano, Marco, Pace Palitti, Valeria, De Matthaeis, Nicoletta, Marzioni, Marco, Gómez-Dominguez, Elena, Montero, Jose-Luis, Molina, Esther, Garcia-Buey, Luisa, Casado, Marta, Berenguer, Marina, Conde, Isabel, Simon, Miguel-Angel, Fuentes, Javier, Costa-Moreira, Pedro, Macedo, Guilherme, Jorquera, Francisco, Morillas, Rosa-Maria, Presa, Jose, Sousa, Jose-Manuel, Gomes, Dario, Santos, Luis, Olveira, Antonio, Hernandez-Guerra, Manuel, Aburruza, Leire, Santos, Arsenio, Carvalho, Armando, Uriz, Juan, Gutierrez, Maria-Luisa, Perez, Elia, Chessa, Luchino, Pellicelli, Adriano, Marignani, Massimo, Muratori, Luigi, Niro, Grazia Anna, Brunetto, Maurizia, Ponziani, Francesca Romana, Pompili, Maurizio, Marra, Fabio, Galli, Andrea, Mussetto, Alessandro, Alagna, Giuliano, Simone, Loredana, Bertino, Gaetano, Rosina, Floriano, Cozzolongo, Raffaele, Russello, Maurizio, Baiocchi, Leonardo, Saitta, Carlo, Terreni, Natalia, Zolfino, Teresa, Rigamonti, Cristina, Vigano, Raffaella, Cuccorese, Giuseppe, Pozzoni, Pietro, Pedone, Claudio, Grasso, Simone, Picardi, Antonio, Invernizzi, Pietro, Sacco, Rodolfo, Izzi, Antonio, Fernandez-Rodriguez, Conrado, Vespasiani-Gentilucci, Umberto, and Carbone, Marco

Published
2024
Full Text
View/download PDF

16. Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication

Author

Salpini, Romina, Piermatteo, Lorenzo, Torre, Giulia, D'Anna, Stefano, Khan, Sohaib, Duca, Leonardo, Bertoli, Ada, La Frazia, Simone, Malagnino, Vincenzo, Teti, Elisabetta, Iannetta, Marco, Paba, Pierpaolo, Ciotti, Marco, Lenci, Ilaria, Francioso, Simona, Paquazzi, Caterina, Lichtner, Miriam, Mastroianni, Claudio, Santopaolo, Francesco, De Sanctis, Giuseppe, Pellicelli, Adriano, Galati, Giovanni, Moretti, Alessandra, Casinelli, Katia, Caterini, Luciano, Iapadre, Nerio, Parruti, Giustino, Vecchiet, Iacopo, Paoloni, Maurizio, Marignani, Massimo, Ceccherini-Silberstein, Francesca, Baiocchi, Leonardo, Grelli, Sandro, Sarmati, Loredana, and Svicher, Valentina

Published
2024
Full Text
View/download PDF

17. HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Author

Pellicelli Adriano M, Romano Mario, Stroffolini Tommaso, Mazzoni Ettore, Mecenate Fabrizio, Monarca Roberto, Picardi Antonio, Bonaventura Maria, Mastropietro Cristina, Vignally Pascal, Andreoli Arnaldo, Marignani Massimo, D’Ambrosio Cecilia, Miglioresi Lucia, Nosotti Lorenzo, Mitidieri Olga, Gentilucci Umberto, Puoti Claudio, Barbaro Giuseppe, Barlattani Angelo, Furlan Caterina, and Barbarini Giorgio

Subjects
Genotype 1a, HCV genotype 1 subtypes, Sustained virological response, Antiviral therapy, Pegylated interferon, Diseases of the digestive system. Gastroenterology, RC799-869
Abstract

Abstract Background The impact of viral subtype on the rate of sustained virological response (SVR) to antiviral therapy in patients chronically infected with hepatitis C genotype 1 subtype 1a and 1b has not been extensively investigated. The aim of this study is to determine whether the HCV genotype 1 subtypes 1a and 1b respond differently to treatment with PEGylated interferon (PEG-IFN) plus ribavirin. Methods For 48 weeks, 388 “naïve”genotype 1 patients were treated weekly with PEG-IFN α-2a or PEG-INF α-2b combined with daily ribavirin (1000–1200 mg/day). The numbers of patients in whom HCV-RNA was undetectable were compared after 4 (rapid virological response, RVR), 12 (early virological response, EVR), and 48 (end treatment virological response, ETR) weeks of treatment as well as 24 weeks after the last treatment (sustained virological response, SVR). Results The rate of SVR was higher in subtype 1a patients than subtype 1b patients (55% vs. 43%; p 10 IU/ml (OR: 3.2; 95% CI: 2.7 to 6.9) and fibrosis score < S3 (OR: 3.8; 95% CI:3.2 to 7.4), were all independent predictors of SVR. Conclusion Dual antiviral therapy is more effective against HCV subtype 1a than against subtype 1b and this difference is independent of other factors that may favour viral clearance. Trial registration ClinicalTrials.gov Identifier: NCT01342003

Published
2012
Full Text
View/download PDF

18. Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial

Author

Picardi Antonio, Arcuri Pasquale, Nosotti Lorenzo, Bonaventura Maria, Mazzoni Ettore, Barlattani Angelo, Romano Mario, Barbaro Giuseppe, Pellicelli Adriano M, Mecenate Fabrizio, Barbarini Giorgio, D'Ambrosio Cecilia, Paffetti Amerigo, Andreoli Arnaldo, and Soccorsi Fabrizio

Subjects
Diseases of the digestive system. Gastroenterology, RC799-869
Abstract

Abstract Background In patients with chronic hepatitis C virus (HCV) genotype 2 or 3, 24 weeks' treatment with pegylated interferon alfa (PEG-IFN-alpha) and ribavirin induces a sustained virological response (SVR) in almost 80% of cases. Evidence suggests that a similar response rate may be obtained with shorter treatment periods, especially in patients with a rapid virological response (RVR). The aim of this study was to compare the efficacy of 12 or 24 weeks of treatment in patients with chronic HCV genotype 2 or 3 and to identify patients suitable for 12 weeks treatment. Methods Two hundred and ten patients received PEG-IFN-alpha-2a (180 ug/week) and ribavirin (800-1200 mg/day) for 4 weeks. Patients with a RVR (HCV RNA not detectable) were randomized (1:1) to either 12 (group A1) or 24 (group A2) weeks of combination therapy. Patients without a RVR continued with 24-weeks' combination therapy (group B). HCV RNA was monitored at weeks 4, 8, 12, and 24, and at week 24 post-treatment. Results At study end, end of treatment response (ETR) was observed in 62 (86%) patients of group A1 and in 55 (77%) patients of group A2 (p < 0.05) Relapse rate was 3% each in groups A1 and A2, and 6% in group B. Among patients with a HCVRNA test 24 weeks after the end of treatment, SVR was observed in 60 (83%) of group A1 patients and in 53 (75%) of group A2 patients. Rapid virological response, low baseline HCV RNA levels, elevated alanine aminotransferase levels and low fibrosis score, were the strongest covariates associated with SVR, independent of HCV genotype. No baseline characteristic was associated with relapse. Conclusion In HCV patients with genotype 2 or 3, 12-week combination therapy is as efficacious as 24-week therapy and several independent covariates were predictive of SVR. Trial registration Trial number ISRCTN29259563

Published
2010
Full Text
View/download PDF

19. Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature

Author

Terranova Antonio, Pino Paolo, Pellicelli Adriano M, D'Ambrosio Cecilia, and Soccorsi Fabrizio

Subjects
Eustachian valve endocarditis, transthoracic echocardiography, intravenous drug abuse, staphylococcus aureus, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Abstract Background Right-sided endocarditis occurs predominantly in intravenous drug users, in patients with pacemaker or central venous lines and in patients with congenital heart disease. The vast majority of cases involve the tricuspid valve. Eustachian valve endocarditis is an uncommon disease with similar signs and symptoms of the tricuspid valve endocarditis. A series of only 16 cases of eustachian valve endocarditis are reported in the literature. Case Presentation We present a case of a 25-year old woman with intravenous drug abuse who had a staphylococcus aureus tricuspid valve endocarditis associated to eustachian valve endocarditis. Transthoracic echocardiography, as first line examination, showed the vegetations on tricuspid and eustachian valve. Conclusion Our case describe an unusual location of right side endocarditis in a intravenous drug abuser. In our case, in accord with other cases described in the literature, transthoracic echocardiography disclosed eustachian valve endocarditis. Antimicrobial management is not altered by the recognition of eustachian valve endocarditis. Antibiotic treatment and duration of eustachian endocarditis depends on the isolated organism and is similar to antibiotic therapy used in native valve endocarditis.

Published
2005
Full Text
View/download PDF

32. Sustainable Mobility and Accessibility to Essential Services. An Assessment of the San Benedetto Neighbourhood in Cagliari (Italy)

Author

Pellicelli, Gloria, Caselli, Barbara, Garau, Chiara, Torrisi, Vincenza, Rossetti, Silvia, Goos, Gerhard, Founding Editor, Hartmanis, Juris, Founding Editor, Bertino, Elisa, Editorial Board Member, Gao, Wen, Editorial Board Member, Steffen, Bernhard, Editorial Board Member, Yung, Moti, Editorial Board Member, Gervasi, Osvaldo, editor, Murgante, Beniamino, editor, Misra, Sanjay, editor, Rocha, Ana Maria A. C., editor, and Garau, Chiara, editor

Published
2022
Full Text
View/download PDF

34. Are Consumers Really Informed on Corporate Social Responsibility Labels for Fishery Products? Results of an Italian Case Study

Author

Varese, Erica, Pellicelli, Anna Claudia, Bollani, Luigi, Kacprzyk, Janusz, Series Editor, Gomide, Fernando, Advisory Editor, Kaynak, Okyay, Advisory Editor, Liu, Derong, Advisory Editor, Pedrycz, Witold, Advisory Editor, Polycarpou, Marios M., Advisory Editor, Rudas, Imre J., Advisory Editor, Wang, Jun, Advisory Editor, and Antipova, Tatiana, editor

Published
2022
Full Text
View/download PDF

35. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

Author

Conti, Filomena, Scatton, Olivier, Bernard, Pierre Henri, Francoz, Claire, Durand, Francois, Dharancy, Sébastien, Woehl, Marie-lorraine, Laurent, Alexis, Radenne, Sylvie, Dumortier, Jérôme, Abergel, Armand, Barbier, Louise, Houssel-Debry, Pauline, Pageaux, Georges Philippe, Chiche, Laurence, Deledinghen, Victor, Hardwigsen, Jean, Gugenheim, J., altieri, M., Hilleret, Marie Noelle, Decaens, Thomas, Costa, Paulo, de Ataide, Elaine Cristina, Quiñones, Emilio, Anders, Margarita, Varón, Adriana, Zerega, Alina, Soza, Alejandro, Machaca, Martín Padilla, Arufe, Diego, Menéndez, Josemaría, Zapata, Rodrigo, Vilatoba, Mario, Muñoz, Linda, Menéndez, Ricardo Chong, Maraschio, Martín, Podestá, Luis G., McCormack, Lucas, Mattera, Juan, Gadano, Adrian, Parente García, Jose Huygens, Magini, Giulia, Miglioresi, Lucia, Gambato, Martina, D’Ambrosio, Cecilia, Vitale, Alessandro, Colledan, Michele, Pinelli, Domenico, Magistri, Paolo, Vennarecci, Giovanni, Colasanti, Marco, Giannelli, Valerio, Pellicelli, Adriano, Eduard, Callebout, Samuele, Iesari, Jeroen, Dekervel, Jonas, Schreiber, Jacques, Pirenne, Chris, Verslype, Dirk, Ysebaert, Peter, Michielsen, Valerio, Lucidi, Christophe, Moreno, Olivier, Detry, Jean, Delwaide, Roberto, Troisi, Paul, Lerut Jan, Piñero, Federico, Costentin, Charlotte, Degroote, Helena, Notarpaolo, Andrea, Boin, Ilka FSF., Boudjema, Karim, Baccaro, Cinzia, Chagas, Aline, Bachellier, Philippe, Ettorre, Giuseppe Maria, Poniachik, Jaime, Muscari, Fabrice, Dibenedetto, Fabrizio, Duque, Sergio Hoyos, Salame, Ephrem, Cillo, Umberto, Marciano, Sebastián, Vanlemmens, Claire, Fagiuoli, Stefano, Carrilho, Flair, Cherqui, Daniel, Burra, Patrizia, Van Vlierberghe, Hans, Lai, Quirino, Silva, Marcelo, Rubinstein, Fernando, and Duvoux, Christophe

Published
2023
Full Text
View/download PDF

37. WED-391 Long-term virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with bulevirtide monotherapy for up to 120 weeks: a retrospective multicenter european study (save-d)

Author

Degasperi, Elisabetta, primary, Anolli, Maria Paola, additional, Jachs, Mathias, additional, Reiberger, Thomas, additional, de Lédinghen, Victor, additional, Metivier, Sophie, additional, D'Offizi, Giampiero, additional, De Maria, Francesco, additional, Schramm, Christoph, additional, Schmidt, Hartmut, additional, Zöllner, Caroline, additional, Tacke, Frank, additional, Dietz-Fricke, Christopher, additional, Wedemeyer, Heiner, additional, Papatheodoridi, Margarita, additional, Papatheodoridis, George, additional, Carey, Ivana, additional, Agarwal, Kosh, additional, van Bömmel, Florian, additional, Brunetto, Maurizia, additional, Cardoso, Mariana, additional, Verucchi, Gabriella, additional, Ciancio, Alessia, additional, Zoulim, Fabien, additional, Aleman, Soo, additional, Semmo, Nasser, additional, Mangia, Alessandra, additional, Hilleret, Marie-Noëlle, additional, Loglio, Alessandro, additional, Merle, Uta, additional, Santantonio, Teresa, additional, Coppola, Nicola, additional, Pellicelli, Adriano, additional, Roche, Bruno, additional, Causse, Xavier, additional, Dalteroche, Louis, additional, Dumortier, Jérôme, additional, Ganne-Carrié, Nathalie, additional, Heluwaert, Frederic, additional, Ollivier-Hourmand, Isabelle, additional, Roulot, Dominique, additional, Federico, Alessandro, additional, Pileri, Francesca, additional, Maracci, Monia, additional, Tonnini, Matteo, additional, Arpurt, Jean-Pierre, additional, Barange, Karl, additional, Billaud, Eric, additional, Pol, Stanislas, additional, Gervais, Anne, additional, Franza, Anne Minello, additional, Rosa, Isabelle, additional, Puoti, Massimo, additional, and Lampertico, Pietro, additional

Published
2024
Full Text
View/download PDF

38. WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)

Author

Anolli, Maria Paola, primary, Degasperi, Elisabetta, additional, D'Offizi, Giampiero, additional, Rianda, Alessia, additional, Loglio, Alessandro, additional, Viganò, Mauro, additional, Ciancio, Alessia, additional, Troshina, Yulia, additional, Brunetto, Maurizia, additional, Coco, Barbara, additional, Zaltron, Serena, additional, Toniutto, Pierluigi, additional, Marinaro, Letizia, additional, Gori, Andrea, additional, Federico, Alessandro, additional, Santantonio, Teresa, additional, Verucchi, Gabriella, additional, Morisco, Filomena, additional, Mangia, Alessandra, additional, De Nicola, Stella, additional, Maracci, Monia, additional, Romano, Antonietta, additional, Gatti, Pietro, additional, Zampino, Rosa, additional, Persico, Marcello, additional, Pozzoni, Pietro, additional, Pellicelli, Adriano, additional, Coppola, Nicola, additional, Pileri, Francesca, additional, Tonnini, Matteo, additional, Puoti, Massimo, additional, and Lampertico, Pietro, additional

Published
2024
Full Text
View/download PDF

39. OS-120 Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis

Author

Degasperi, Elisabetta, primary, De Silvestri, Annalisa, additional, Anolli, Maria Paola, additional, Sambarino, Dana, additional, Borghi, Marta, additional, Perbellini, Riccardo, additional, Facchetti, Floriana, additional, Soffredini, Roberta, additional, Monico, Sara, additional, de Lédinghen, Victor, additional, Metivier, Sophie, additional, Jachs, Mathias, additional, Reiberger, Thomas, additional, D'Offizi, Giampiero, additional, Dietz-Fricke, Christopher, additional, Papatheodoridis, George, additional, Brunetto, Maurizia, additional, Verucchi, Gabriella, additional, Ciancio, Alessia, additional, Zoulim, Fabien, additional, Mangia, Alessandra, additional, Hilleret, Marie-Noëlle, additional, Santantonio, Teresa, additional, Coppola, Nicola, additional, Pellicelli, Adriano, additional, Roche, Bruno, additional, Causse, Xavier, additional, Dalteroche, Louis, additional, Dumortier, Jérôme, additional, Ganne-Carrié, Nathalie, additional, Heluwaert, Frederic, additional, Ollivier-Hourmand, Isabelle, additional, Loglio, Alessandro, additional, Federico, Alessandro, additional, Pileri, Francesca, additional, Maracci, Monia, additional, Tonnini, Matteo, additional, Arpurt, Jean-Pierre, additional, Barange, Karl, additional, Billaud, Eric, additional, Pol, Stanislas, additional, Gervais, Anne, additional, Franza, Anne Minello, additional, Rosa, Isabelle, additional, Puoti, Massimo, additional, and Lampertico, Pietro, additional

Published
2024
Full Text
View/download PDF

43. Traumatic potential of Recurrent Implantation Failure in Assisted Reproductive Technology paths for couples experiencing infertility

Author

Chiara Fusco, Pier Luigi Righetti, Camilla Pellicelli, Chiara Masaro, Silvia Longo, and Vincenzo Calvo

Subjects
recurrent implantation failure, infertility, assisted reproductive technology, couple, reproductive trauma., Psychology, BF1-990
Abstract

Heterosexual couples dealing with infertility can seek Assisted Reproductive Technology (ART) treatments to achieve pregnancy. Within these programs, infertile couples can experience Recurrent Implantation Failure (RIF), which is the failure to achieve a clinical pregnancy after three or more transfers of good-quality embryos into the uterus. RIF also refers to cases of biochemical pregnancy in which increased levels of Beta hCG hormone are detected without subsequent signs of clinical pregnancy. Although the psychological literature has shown that the repetition of ART attempts significantly correlates with negative psychological outcomes for men and women, to date there are no studies regarding the potentially traumatic features of RIF experiences. Hence, we provide an overview of the extant literature to highlight points of contact between the features of traumatic experiences and those of RIF and infertility, including the specific characteristics that make the population of infertile couples in ART programs potentially more vulnerable to trauma. This article aims to stimulate reflection in this area and emphasize the importance of expanding research to deepen our knowledge of the psychological processes involved in RIF conditions within ART treatments for infertile couples.

Published
2023
Full Text
View/download PDF

46. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

Author

Boudjema, Karim, Bachellier, Philippe, Conti, Filomena, Scatton, Olivier, Muscari, Fabrice, Salame, Ephrem, Bernard, Pierre Henri, Francoz, Claire, Durand, Francois, Dharancy, Sébastien, Woehl, Marie-lorraine, Vanlemmens, Claire, Laurent, Alexis, Radenne, Sylvie, Dumortier, Jérôme, Abergel, Armand, Cherqui, Daniel, Barbier, Louise, Houssel-Debry, Pauline, Pageaux, Georges Philippe, Chiche, Laurence, Deledinghen, Victor, Hardwigsen, Jean, Gugenheim, J., Altieri, M., Hilleret, Marie Noelle, Decaens, Thomas, Duvoux, Christophe, Piñero, Federico, Chagas, Aline, Costa, Paulo, Cristina de Ataide, Elaine, Quiñones, Emilio, Duque, Sergio Hoyos, Marciano, Sebastián, Anders, Margarita, Varón, Adriana, Zerega, Alina, Poniachik, Jaime, Soza, Alejandro, Machaca, Martín Padilla, Arufe, Diego, Menéndez, Josemaría, Zapata, Rodrigo, Vilatoba, Mario, Muñoz, Linda, Menéndez, Ricardo Chong, Maraschio, Martín, Podestá, Luis G., McCormack, Lucas, Mattera, Juan, Gadano, Adrian, Fatima Boin, Ilka S.F., Parente García, Jose Huygens, Carrilho, Flair, Silva, Marcelo, Notarpaolo, Andrea, Magini, Giulia, Miglioresi, Lucia, Gambato, Martina, Di Benedetto, Fabrizio, D’Ambrosio, Cecilia, Ettorre, Giuseppe Maria, Vitale, Alessandro, Burra, Patrizia, Fagiuoli, Stefano, Cillo, Umberto, Colledan, Michele, Pinelli, Domenico, Magistri, Paolo, Vennarecci, Giovanni, Colasanti, Marco, Giannelli, Valerio, Pellicelli, Adriano, Baccaro, Cizia, Lai, Quirino, Degroote, Helena, Van Vlierberghe, Hans, Eduard, Callebout, Samuele, Iesari, Jeroen, Dekervel, Jonas, Schreiber, Jacques, Pirenne, Chris, Verslype, Dirk, Ysebaert, Peter, Michielsen, Valerio, Lucidi, Christophe, Moreno, Olivier, Detry, Jean, Delwaide, Roberto, Troisi, Paul, Lerut Jan, Costentin, Charlotte, Boin, Ilka F., Baccaro, Cinzia, Dibenedetto, Fabrizio, Marciano, Sebastian, and Rubinstein, Fernando

Published
2022
Full Text
View/download PDF

50. Urban regeneration to enhance sustainable mobility

Author

Gloria Pellicelli, Silvia Rossetti, Barbara Caselli, and Michele Zazzi

Subjects
sustainable mobility, urban redevelopment, urban regeneration, public spaces, Transportation engineering, TA1001-1280, Urbanization. City and country, HT361-384
Abstract

Urban regeneration processes represent an opportunity to pursue a sustainable city model. From a sustainable city perspective, the contribution to the redesign of public space and mobility infrastructures and to the improvement of pedestrian and cycle accessibility to local public services is undoubtedly significant. Within this framework, the Italian Region of Emilia-Romagna, promoted an Urban regeneration Call in 2018 to which cities submitted project proposals concerning the redevelopment of both architectural emergencies and public open spaces, paying particular attention to sustainable mobility issues. About 100 proposals have been submitted and several municipalities received funding. This paper analyses in particular the proposals submitted by the provincial capital cities, through a comparative approach, focusing on mobility, accessibility improvements and open space redevelopment. The aim is to highlight similarities and differences in order to identify some common guiding principles for enhancing sustainable urban mobility.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results